EE05394B1 - Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis - Google Patents

Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis

Info

Publication number
EE05394B1
EE05394B1 EEP200500033A EEP200500033A EE05394B1 EE 05394 B1 EE05394 B1 EE 05394B1 EE P200500033 A EEP200500033 A EE P200500033A EE P200500033 A EEP200500033 A EE P200500033A EE 05394 B1 EE05394 B1 EE 05394B1
Authority
EE
Estonia
Prior art keywords
treatment
quinoline compounds
latent tuberculosis
tuberculosis
latent
Prior art date
Application number
EEP200500033A
Other languages
English (en)
Estonian (et)
Inventor
Jozef Lodewijk Marcel Andries Koenraad
Koul Anil
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35717702&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE05394(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of EE200500033A publication Critical patent/EE200500033A/xx
Publication of EE05394B1 publication Critical patent/EE05394B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP200500033A 2004-12-24 2005-12-05 Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis EE05394B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04078529 2004-12-24
EP05105008 2005-06-08

Publications (2)

Publication Number Publication Date
EE200500033A EE200500033A (et) 2006-08-15
EE05394B1 true EE05394B1 (et) 2011-04-15

Family

ID=35717702

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200500033A EE05394B1 (et) 2004-12-24 2005-12-05 Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis

Country Status (30)

Country Link
US (1) US20060142279A1 (fr)
EP (1) EP1830850B1 (fr)
CN (1) CN103142595B (fr)
AP (1) AP2327A (fr)
AR (1) AR051790A1 (fr)
AT (1) ATE501721T1 (fr)
AU (1) AU2005242138B2 (fr)
BR (1) BRPI0506400B8 (fr)
CA (1) CA2529265C (fr)
CR (1) CR9267A (fr)
CY (1) CY1112247T1 (fr)
DE (1) DE602005026984D1 (fr)
DK (1) DK1830850T3 (fr)
EE (1) EE05394B1 (fr)
HR (1) HRP20110392T1 (fr)
IL (1) IL184123A (fr)
LV (1) LV13469B (fr)
ME (1) ME01207B (fr)
MY (1) MY145845A (fr)
NI (1) NI200700146A (fr)
NO (1) NO340376B1 (fr)
NZ (1) NZ555460A (fr)
PA (1) PA8654801A1 (fr)
PL (1) PL1830850T3 (fr)
PT (1) PT1830850E (fr)
RS (1) RS51730B (fr)
SI (1) SI1830850T1 (fr)
TR (1) TR200504892A1 (fr)
TW (1) TWI404535B (fr)
WO (1) WO2006067048A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1527050T3 (da) * 2002-07-25 2010-07-19 Janssen Pharmaceutica Nv Quinolin-derivater og deres anvendelse som mycobakterielle inhibitorer
JO3270B1 (ar) * 2005-06-28 2018-09-16 Janssen Pharmaceutica Nv مشتقات كوينولين بصفة عوامل مضادة للبكتيريا
JO2752B1 (en) 2005-06-28 2014-03-15 شركة جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
AU2006263882B2 (en) * 2005-06-28 2012-12-13 Janssen Pharmaceutica N.V Quinoline derivatives as antibacterial agents
JO2725B1 (en) * 2006-12-06 2013-09-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2683B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2970B1 (en) * 2006-12-06 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO3271B1 (ar) * 2006-12-06 2018-09-16 Janssen Pharmaceutica Nv مشتقات الكوينولين المضادة للجراثيم
CA2711912A1 (fr) * 2008-01-14 2009-07-23 Jyoti Chattopadhyaya Derives de quinoleine, de naphtalene, de quinoleine ou de naphtalene contraint au niveau conformation en tant qu'agents antimycobacteriens
RU2404971C2 (ru) * 2008-12-02 2010-11-27 ЗАО "Фарм-Синтез" Новые производные хинолина, способ их получения, их применение для лечения микобактериальных инфекций, фармацевтическая композиция на их основе
US8741917B2 (en) 2009-01-15 2014-06-03 Rutgers, The State University Of New Jersey Benzo [C] phenanthridines as antimicrobial agents
US20120059026A1 (en) 2009-04-30 2012-03-08 University Of Medicine And Dentistry Of New Jersey Antimicrobial agents
WO2011156626A1 (fr) 2010-06-09 2011-12-15 Rutgers, The State University Of New Jersey Agents antimicrobiens
CA2803890A1 (fr) * 2010-06-25 2011-12-29 Rutgers, The State University Of New Jersey Agents antimicrobiens
US9822108B2 (en) 2012-01-13 2017-11-21 Rutgers, The State University Of New Jersey Antimicrobial agents
US9475783B2 (en) 2012-03-21 2016-10-25 Rutgers, The State University Of New Jersey Antimicrobial agents
KR102110355B1 (ko) 2012-04-27 2020-05-14 얀센 파마슈티카 엔.브이. 항균성 퀴놀린 유도체
CA2869453C (fr) 2012-04-27 2021-03-02 Janssen Pharmaceutica Nv Derives de quinoleine antibacteriens
US9458150B2 (en) 2013-11-08 2016-10-04 Rutgers, The State University Of New Jersey Antimicrobial agents
LT3250182T (lt) 2015-01-27 2023-07-10 Janssen Pharmaceutica Nv Dispersinės kompozicijos
WO2017147316A1 (fr) 2016-02-25 2017-08-31 Taxis Pharmaceuticals, Inc. Procédés et intermédiaires de synthèse
ES2934785T3 (es) * 2016-03-07 2023-02-27 Global Alliance For Tb Drug Development Inc Compuestos antibacterianos y usos de los mismos
RU2629369C1 (ru) * 2016-10-05 2017-08-29 Федеральное Государственное Унитарное Предприятие "Государственный Ордена Трудового Красного Знамени Научно-Исследовательский Институт Химических Реактивов И Особо Чистых Химических Веществ" Четвертичные аммонийные производные 2-аминотиофен-3-карбоксилатов, обладающие противотуберкулезной активностью
US10774093B2 (en) 2017-03-30 2020-09-15 Taxis Pharmaceuticals, Inc. Synthetic processes and synthetic intermediates
JOP20200004B1 (ar) 2017-07-14 2023-09-17 Janssen Pharmaceutica Nv تركيبات طويلة المفعول
RU2661151C1 (ru) * 2017-12-14 2018-07-12 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Селективные ингибиторы глицеральдегид-3-фосфатдегидрогеназы микобактерий
WO2020144197A1 (fr) 2019-01-09 2020-07-16 Janssen Pharmaceutica Nv Combinaison dans le traitement de maladies mycobactériennes non tuberculeuses
JP2023532982A (ja) 2020-07-09 2023-08-01 ヤンセン ファーマシューティカ エヌ．ベー． 長時間作用型配合物
KR20230038521A (ko) 2020-07-09 2023-03-20 얀센 파마슈티카 엔.브이. 장기 작용 제형
CN116406270A (zh) 2020-11-12 2023-07-07 詹森药业有限公司 在治疗非结核分枝杆菌疾病时的贝达喹啉、乙胺丁醇和大环内酯的组合
WO2023232838A1 (fr) 2022-05-31 2023-12-07 Janssen Pharmaceutica Nv Bédaquiline destinée à être utilisée dans le traitement de la lèpre
WO2024068693A1 (fr) 2022-09-28 2024-04-04 Janssen Pharmaceutica Nv Formulations à action prolongée
WO2024068699A1 (fr) 2022-09-28 2024-04-04 Janssen Pharmaceutica Nv Formulations à action prolongée
WO2025068448A1 (fr) 2023-09-28 2025-04-03 Janssen Pharmaceutica Nv Inhibiteurs de l'atp synthase destinés à être utilisés dans le traitement de mycobactéries non tuberculeuses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR038536A1 (es) * 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
DK1527050T3 (da) * 2002-07-25 2010-07-19 Janssen Pharmaceutica Nv Quinolin-derivater og deres anvendelse som mycobakterielle inhibitorer

Also Published As

Publication number Publication date
DK1830850T3 (da) 2011-06-14
AU2005242138A1 (en) 2006-07-13
WO2006067048A1 (fr) 2006-06-29
BRPI0506400B8 (pt) 2021-05-25
CN103142595A (zh) 2013-06-12
CA2529265C (fr) 2014-02-11
ME01207B (fr) 2013-03-20
EP1830850B1 (fr) 2011-03-16
ATE501721T1 (de) 2011-04-15
RS51730B (sr) 2011-10-31
EP1830850A1 (fr) 2007-09-12
AU2005242138B2 (en) 2011-05-26
PL1830850T3 (pl) 2011-07-29
CY1112247T1 (el) 2015-12-09
AP2327A (en) 2011-11-25
MY145845A (en) 2012-04-30
NO340376B1 (no) 2017-04-10
TWI404535B (zh) 2013-08-11
BRPI0506400A8 (pt) 2017-09-12
CR9267A (es) 2008-09-09
IL184123A (en) 2011-10-31
SI1830850T1 (sl) 2011-07-29
NZ555460A (en) 2008-11-28
CN103142595B (zh) 2015-05-06
TR200504892A1 (tr) 2010-04-21
PT1830850E (pt) 2011-05-31
HRP20110392T1 (hr) 2011-06-30
US20060142279A1 (en) 2006-06-29
AP2007004054A0 (en) 2007-06-30
EE200500033A (et) 2006-08-15
DE602005026984D1 (de) 2011-04-28
LV13469B (en) 2007-01-20
IL184123A0 (en) 2008-12-29
NI200700146A (es) 2019-05-10
PA8654801A1 (es) 2006-08-03
NO20073823L (no) 2007-07-23
AR051790A1 (es) 2007-02-07
TW200637551A (en) 2006-11-01
BRPI0506400B1 (pt) 2021-04-06
CA2529265A1 (fr) 2006-06-24
HK1186125A1 (en) 2014-03-07
BRPI0506400A (pt) 2006-08-29

Similar Documents

Publication Publication Date Title
EE05394B1 (et) Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis
CY2017013I2 (el) ΑΝΤΙΣΩΜΑ ΕΝΑΝΤΙΟΝ PDGFR-α ΓΙΑ ΧΡΗΣΗ ΣΤΗΝ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ ΟΓΚΩΝ
SI3424932T1 (sl) Boronoftalidi za terapevtsko uporabo
IL181524A0 (en) Heterocyclic compounds and methods of use
DK1720554T3 (da) Anvendelse af meloxicam til behandling af luftvejssygdomme hos svin
ATE531720T1 (de) Aza-benzofuranylverbindungen und anwendungsverfahren dafür
DE602005015215D1 (de) Orthosubstituierte aryl- oder heteroarylamidverbindungen
NO20070251A (no) Brønnbehandling
NO20070297A (no) Brønnbehandling
ZA200701193B (en) The use of N-aryl diazaspiracyclic compounds in the treatment of addiction
DE602005018315D1 (de) Rollstuhl
DK3403657T3 (da) Anvendelse af oligouronater til behandling af slimhyperviskositet
IL181819A (en) Use of benzo-fused compounds for the preparation of a medicament and methods making use of said compounds
HRP20150320T1 (xx) Formulacije i metode za lijeäśenje amiloidoze
EP2111484A4 (fr) Agent de brillance polyamine
PT1763520E (pt) Utilização de benzopiranonas trissubstituídas
ZA200705160B (en) Quinoline derivatives for the treatment of latent tuberculosis
FI20040180L (fi) Koostumus psoriasis-taudin hoitamiseksi
EP1759020A4 (fr) Acacs utilises comme genes modificateurs de la voie igf et leurs procedes d'utilisation
DK2301576T3 (da) Terapeutisk anvendelse af anti-CS1-antistoffer
SE0400718D0 (sv) Therapeutic agents
SE0403119D0 (sv) Therapeutic agents
SE0400613D0 (sv) New compounds and use thereof
SE0402780D0 (sv) Therapeutic agents
HUE036189T2 (hu) Monofenol, benzoldiol vagy szulfhidril vegyületek melanómák kezelésében való alkalmazásra

Legal Events

Date Code Title Description
HC1A Change of owner name